Showing results (51-60 of 159) with videos related to
Sort By:
Pageof 16
Drug Safety|October 17, 2002
Comparative tolerability of systemic treatments for plaque-type psoriasisStacy L McClure, Jayme Valentine, Kenneth B GordonDermatologic Therapy|October 23, 2009
Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?Eihab A Alwawi, Eliana Krulig, Kenneth B GordonJournal of the American Academy of Dermatology|March 19, 2017
Association of psoriasis and psoriatic arthritis with osteoporosis and pathological fracturesParul Kathuria, Kenneth B Gordon, Jonathan I SilverbergClinics in Liver Disease|July 5, 2020
Cutaneous Manifestations of Chronic Liver DiseaseAshaki D Patel, Kimberly Katz, Kenneth B GordonJAMA|August 25, 2011
Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trialsCaitriona Ryan, Craig L Leonardi, James G Krueger, et al.Dermatology and Therapy|December 4, 2012
A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2Bruce E Strober, Jennifer Clay Cather, David Cohen, et al.Dermatology and Therapy|December 4, 2012
A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1Bruce E Strober, Jennifer Clay Cather, David Cohen, et al.Therapeutics and Clinical Risk Management|August 30, 2008
Treating psoriasis with adalimumabEihab A Alwawi, Stephanie L Mehlis, Kenneth B GordonJournal of Dermatological Science|August 11, 2007
Targeting TNFalpha rapidly reduces density of dendritic cells and macrophages in psoriatic plaques with restoration of epidermal keratinocyte differentiationDeborah J Marble, Kenneth B Gordon, Brian J NickoloffExpert Review of Clinical Immunology|August 1, 2013
Rationale and early clinical data on IL-17 blockade in psoriasisSteven M Nwe, Amanda H Champlain, Kenneth B GordonPageof 16